A Trial of Rectal Indomethacin to Prevent Post-ERCP Pancreatitis in Patients with Suspected Type 3 Sphincter of Oddi Dysfunction
Crossref DOI link: https://doi.org/10.1007/s10620-015-3643-7
Published Online: 2015-04-14
Published Print: 2015-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Siddiqui, Ali A.
Patel, Devi
Kaplan, Jeremy
Zabolotsky, Andrew H.
Loren, David
Kowalski, Thomas
Ghumman, Saad S.
Adler, Douglas G.
Munigal, Satish
Hayat, Umar
Eloubeidi, Mohamad A.
Text and Data Mining valid from 2015-04-14